Cargando…

Established and Emerging Approaches for the Management of Dyslipidaemia

The key role of dyslipidaemia in determining cardiovascular disease (CVD) has been proved beyond reasonable doubt, and therefore several dietary and pharmacological approaches have been developed. The discovery of statins has provided a very effective approach in reducing cardiovascular risk as docu...

Descripción completa

Detalles Bibliográficos
Autor principal: Norata, Giuseppe Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820450/
https://www.ncbi.nlm.nih.gov/pubmed/24278703
http://dx.doi.org/10.6064/2012/482423
_version_ 1782290138665058304
author Norata, Giuseppe Danilo
author_facet Norata, Giuseppe Danilo
author_sort Norata, Giuseppe Danilo
collection PubMed
description The key role of dyslipidaemia in determining cardiovascular disease (CVD) has been proved beyond reasonable doubt, and therefore several dietary and pharmacological approaches have been developed. The discovery of statins has provided a very effective approach in reducing cardiovascular risk as documented by the results obtained in clinical trials and in clinical practice. The current efficacy of statins or other drugs, however, comes short of providing the benefit that could derive from a further reduction of LDL cholesterol (LDL-C) in high-risk and very high risk patients. Furthermore, experimental data clearly suggest that other lipoprotein classes beyond LDL play important roles in determining cardiovascular risk. For these reasons a number of new potential drugs are under development in this area. Aim of this review is to discuss the available and the future pharmacological strategies for the management of dyslipidemia.
format Online
Article
Text
id pubmed-3820450
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-38204502013-11-25 Established and Emerging Approaches for the Management of Dyslipidaemia Norata, Giuseppe Danilo Scientifica (Cairo) Review Article The key role of dyslipidaemia in determining cardiovascular disease (CVD) has been proved beyond reasonable doubt, and therefore several dietary and pharmacological approaches have been developed. The discovery of statins has provided a very effective approach in reducing cardiovascular risk as documented by the results obtained in clinical trials and in clinical practice. The current efficacy of statins or other drugs, however, comes short of providing the benefit that could derive from a further reduction of LDL cholesterol (LDL-C) in high-risk and very high risk patients. Furthermore, experimental data clearly suggest that other lipoprotein classes beyond LDL play important roles in determining cardiovascular risk. For these reasons a number of new potential drugs are under development in this area. Aim of this review is to discuss the available and the future pharmacological strategies for the management of dyslipidemia. Hindawi Publishing Corporation 2012 2012-09-10 /pmc/articles/PMC3820450/ /pubmed/24278703 http://dx.doi.org/10.6064/2012/482423 Text en Copyright © 2012 Giuseppe Danilo Norata. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Norata, Giuseppe Danilo
Established and Emerging Approaches for the Management of Dyslipidaemia
title Established and Emerging Approaches for the Management of Dyslipidaemia
title_full Established and Emerging Approaches for the Management of Dyslipidaemia
title_fullStr Established and Emerging Approaches for the Management of Dyslipidaemia
title_full_unstemmed Established and Emerging Approaches for the Management of Dyslipidaemia
title_short Established and Emerging Approaches for the Management of Dyslipidaemia
title_sort established and emerging approaches for the management of dyslipidaemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820450/
https://www.ncbi.nlm.nih.gov/pubmed/24278703
http://dx.doi.org/10.6064/2012/482423
work_keys_str_mv AT noratagiuseppedanilo establishedandemergingapproachesforthemanagementofdyslipidaemia